Home pageIX1 • ETR
add
IDEXX
Chiusura precedente
612,00 €
Intervallo giornaliero
615,40 € - 617,20 €
Intervallo annuale
517,00 € - 663,20 €
Cap di mercato
57,12Â Mld USD
Volume medio
16,00
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
NASDAQ
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 1,11Â Mld | 13,29% |
Spese di gestione | 328,51Â Mln | 12,45% |
Utile netto | 274,61Â Mln | 17,94% |
Margine di profitto netto | 24,85 | 4,11% |
Utili per azione | 3,40 | 21,43% |
EBITDA | 391,47Â Mln | 15,81% |
Aliquota fiscale effettiva | 20,35% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 208,17Â Mln | -32,55% |
Totale attivo | 3,39Â Mld | 1,07% |
Totale passivo | 1,83Â Mld | 5,36% |
Patrimonio netto totale | 1,56 Mld | — |
Azioni in circolazione | 79,85 Mln | — |
Prezzo/valore contabile | 31,35 | — |
Redditività dell'attivo | 26,41% | — |
Rendimento sul capitale | 33,04% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 274,61Â Mln | 17,94% |
Liquidità di esercizio | 402,34 Mln | 82,82% |
Contanti da investimenti | -44,87Â Mln | -63,95% |
Contanti da finanziamenti | -313,31Â Mln | -7,67% |
Flusso di cassa netto | 43,57Â Mln | 146,87% |
Flusso di cassa libero | 226,67Â Mln | 32,11% |
Informazioni
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
CEO
Fondazione
19 dic 1983
Sito web
Dipendenti
11.000